Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
St Antonius Hospital in Nieuwegein, the Netherlands, uses a soluble interleukin-2 receptor (sIL-2R) ELISA from Tecan in the investigation, management and monitoring of interstitial lung disease. This easy-to-use assay is the world’s first...
The European Union’s In Vitro Diagnostics Regulation (IVDR) replaces the In Vitro Diagnostic Medical Devices Directive (IVDD), completely overhauling the regulations regarding pre- and post- market requirements for IVD devices. This has implications...